BioCryst Pharmaceuticals, Inc. (BCRX) Upgraded to Hold by ValuEngine
A number of other research firms have also recently weighed in on BCRX. Noble Financial reaffirmed a buy rating on shares of BioCryst Pharmaceuticals in a research report on Saturday, May 6th.
from Biotech News
0 Comments